{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:55:07Z","timestamp":1792803307384,"version":"4.5.0"},"reference-count":362,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T00:00:00Z","timestamp":1671235200000},"content-version":"am","delay-in-days":291,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.autrev.2021.103016","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T20:07:44Z","timestamp":1639426064000},"page":"103016","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Fc receptors gone wrong: A comprehensive review of their roles in autoimmune and inflammatory diseases"],"prefix":"10.1016","volume":"21","author":[{"given":"Emilie","family":"Chalayer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baptiste","family":"Gramont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Zekre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Goguyer-Deschaumes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Waeckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucile","family":"Grange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy W.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Killian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2021.103016_bb0005","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.autrev.2012.10.008","article-title":"The role of Fc receptors and complement in autoimmunity","volume":"12","author":"Mihai","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.103016_bb0010","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.autrev.2016.02.006","article-title":"Targeting Fc\u03b3Rs to treat antibody-dependent autoimmunity","volume":"15","author":"Yu","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.103016_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102366","article-title":"Next-generation fc receptor-targeting biologics for autoimmune diseases","volume":"18","author":"Zuercher","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.103016_bb0020","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fimmu.2014.00254","article-title":"Contribution of human Fc\u03b3Rs to disease with evidence from human polymorphisms and transgenic animal studies","volume":"5","author":"Gillis","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0025","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/978-3-319-07911-0_13","article-title":"Human FcR polymorphism and disease","volume":"382","author":"Li","year":"2014","journal-title":"Fc Recept"},{"key":"10.1016\/j.autrev.2021.103016_bb0030","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3389\/fimmu.2019.00811","article-title":"Understanding Fc receptor involvement in inflammatory diseases: from mechanisms to new therapeutic tools","volume":"10","author":"Ben Mkaddem","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0035","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.autrev.2016.07.035","article-title":"Fc-gamma receptors: attractive targets for autoimmune drug discovery searching for intelligent therapeutic designs","volume":"15","author":"Bosques","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.103016_bb0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1600-065X.1988.tb00765.x","article-title":"Role of IgD and T\u03b4 cells in the regulation of the humoral immune response","volume":"105","author":"Coico","year":"1988","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2021.103016_bb0045","doi-asserted-by":"crossref","first-page":"9772","DOI":"10.1073\/pnas.171308498","article-title":"Identification of a family of Fc receptor homologs with preferential B cell expression","volume":"98","author":"Davis","year":"2001","journal-title":"Proc Natl Acad Sci"},{"issue":"Suppl. 3","key":"10.1016\/j.autrev.2021.103016_bb0050","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1186\/ar578","article-title":"Epidemiology and genetics of rheumatoid arthritis","volume":"4","author":"Silman","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1016\/j.autrev.2021.103016_bb0055","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"The Lancet"},{"key":"10.1016\/j.autrev.2021.103016_bb0060","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1136\/annrheumdis-2013-204627","article-title":"The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study","volume":"73","author":"Cross","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.103016_bb0065","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update","volume":"79","author":"Smolen","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.103016_bb0070","doi-asserted-by":"crossref","first-page":"12068","DOI":"10.1038\/s41598-019-48176-3","article-title":"Citrullination facilitates cross-reactivity of rheumatoid factor with non-IgG1 Fc epitopes in rheumatoid arthritis","volume":"9","author":"Trela","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2021.103016_bb0075","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1159\/000508239","article-title":"Mouse models of rheumatoid arthritis for studies on immunopathogenesis and preclinical testing of Fc receptor-targeting biologics","volume":"105","author":"Lewis","year":"2020","journal-title":"Pharmacology"},{"key":"10.1016\/j.autrev.2021.103016_bb0080","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-018-1584-1","article-title":"Fc\u03b3 receptor-mediated influx of S100A8\/A9-producing neutrophils as inducer of bone erosion during antigen-induced arthritis","volume":"20","author":"Di Ceglie","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2021.103016_bb0085","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF00919382","article-title":"The biology and pathology of Fc receptors","volume":"13","author":"Sandor","year":"1993","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0090","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1002\/art.20672","article-title":"A shift in the balance of inhibitory and activating Fc\u03b3 receptors on monocytes toward the inhibitory Fc\u03b3 receptor IIb is associated with prevention of monocyte activation in rheumatoid arthritis","volume":"50","author":"Wijngaarden","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.103016_bb0095","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1172\/JCI24772","article-title":"Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions","volume":"115","author":"Boruchov","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2021.103016_bb0100","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1046\/j.1365-2567.1997.00249.x","article-title":"Neutrophils from the synovial fluid of patients with rheumatoid arthritis express the high affinity immunoglobulin G receptor, Fc gamma RI (CD64): role of immune complexes and cytokines in induction of receptor expression","volume":"91","author":"Quayle","year":"1997","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2021.103016_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00079","article-title":"Control of cytokine production by human Fc gamma receptors: implications for pathogen defense and autoimmunity","volume":"6","author":"Vogelpoel","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0110","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/art.10721","article-title":"Coordinate expression of activating Fc gamma receptors I and III and inhibiting Fc gamma receptor type II in the determination of joint inflammation and cartilage destruction during immune complex-mediated arthritis","volume":"48","author":"Nabbe","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.103016_bb0115","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/art.41386","article-title":"Fc\u03b3 receptor I-coupled signaling in peripheral nociceptors mediates joint pain in a rat model of rheumatoid arthritis","volume":"72","author":"Liu","year":"2020","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.autrev.2021.103016_bb0120","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/art.30081","article-title":"Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and Fc\u03b3 receptor","volume":"63","author":"Sokolove","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.103016_bb0125","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1038\/ncomms6444","article-title":"Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages","volume":"5","author":"Vogelpoel","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2021.103016_bb0130","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/jemt.10299","article-title":"S100A9\/S100A8: myeloid representatives of the S100 protein family as prominent players in innate immunity","volume":"60","author":"Nacken","year":"2003","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.autrev.2021.103016_bb0135","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/rheumatology\/kep452","article-title":"Synovial fluid proteomic fingerprint: S100A8, S100A9 and S100A12 proteins discriminate rheumatoid arthritis from other inflammatory joint diseases","volume":"49","author":"Baillet","year":"2010","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.autrev.2021.103016_bb0140","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.molmed.2018.12.008","article-title":"Neutrophils in rheumatoid arthritis: breaking immune tolerance and Fueling disease","volume":"25","author":"O\u2019Neil","year":"2019","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.autrev.2021.103016_bb0145","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.4049\/jimmunol.167.3.1601","article-title":"Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis","volume":"167","author":"Wipke","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0150","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1073\/pnas.1914186117","article-title":"IL-4 controls activated neutrophil Fc\u03b3R2b expression and migration into inflamed joints","volume":"117","author":"Panda","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2021.103016_bb0155","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.autrev.2015.01.013","article-title":"Citrullination and autoimmunity","volume":"14","author":"Valesini","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.103016_bb0160","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/art.37741","article-title":"Activation of human synovial mast cells from rheumatoid arthritis or osteoarthritis patients in response to aggregated IgG through Fc\u03b3 receptor I and Fc\u03b3 receptor II","volume":"65","author":"Lee","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.103016_bb0165","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/art.10230","article-title":"Differential role of neutrophil Fc\u03b3 receptor IIIB (CD16) in phagocytosis, bacterial killing, and responses to immune complexes","volume":"46","author":"Fossati","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.103016_bb0170","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/toxsci\/kfr278","article-title":"Nonclinical evaluation of GMA161\u2014an antihuman CD16 (Fc\u03b3RIII) monoclonal antibody for treatment of autoimmune disorders in CD16 transgenic mice","volume":"125","author":"Flaherty","year":"2012","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.autrev.2021.103016_bb0175","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12865-019-0328-6","article-title":"Using the K\/BxN mouse model of endogenous, chronic, rheumatoid arthritis for the evaluation of potential immunoglobulin-based therapeutic agents, including IVIg and Fc-\u03bcTP-L309C, a recombinant IgG1 Fc hexamer","volume":"20","author":"Lewis","year":"2019","journal-title":"BMC Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0180","doi-asserted-by":"crossref","first-page":"7272","DOI":"10.4049\/jimmunol.0803497","article-title":"Recombinant soluble human Fc\u03b3R1A (CD64A) reduces inflammation in murine collagen-induced arthritis","volume":"182","author":"Ellsworth","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0185","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1056\/NEJMoa1000500","article-title":"An Oral spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis","volume":"363","author":"Weinblatt","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2021.103016_bb0190","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.4049\/jimmunol.1800583","article-title":"Efficacy and pharmacodynamic modeling of the BTK inhibitor evobrutinib in autoimmune disease models","volume":"202","author":"Haselmayer","year":"2019","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02061","article-title":"The complex association of Fc\u03b3RIIb with autoimmune susceptibility","volume":"10","author":"Verbeek","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0200","doi-asserted-by":"crossref","first-page":"R64","DOI":"10.1186\/ar1926","article-title":"Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells","volume":"8","author":"Mathsson","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2021.103016_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114360","article-title":"The prospects for targeting FcR as a novel therapeutic strategy in rheumatoid arthritis","volume":"183","author":"Wu","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.autrev.2021.103016_bb0210","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.clim.2008.02.002","article-title":"Amelioration of collagen-induced arthritis by human recombinant soluble Fc\u03b3RIIb","volume":"127","author":"Magnusson","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0215","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1016\/j.molimm.2008.06.027","article-title":"Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcgammaRIIb with Fc-engineered antibodies","volume":"45","author":"Chu","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0220","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/art.38334","article-title":"Suppression of rheumatoid arthritis B cells by XmAb5871, an anti-CD19 antibody that coengages B cell antigen receptor complex and Fc\u03b3 receptor IIb inhibitory receptor","volume":"66","author":"Chu","year":"2014","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.autrev.2021.103016_bb0225","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/annrheumdis-2015-eular.2851","article-title":"FRI0161 a phase 1B\/2A study of the safety, tolerability, pharmacokinetics and pharmacodynamics of XMAB\u00ae5871 in patients with rheumatoid arthritis","volume":"74","author":"Jaraczewska-Baumann","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.103016_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/biom9080373","article-title":"Human FcRn tissue expression profile and half-life in PBMCs","volume":"9","author":"Fan","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.autrev.2021.103016_bb0235","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.3390\/ijms22063048","article-title":"In translation: FcRn across the therapeutic spectrum","volume":"22","author":"Qi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2021.103016_bb0240","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jaci.2020.07.015","article-title":"Neonatal Fc receptor in human immunity: function and role in therapeutic intervention","volume":"146","author":"Patel","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0245","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200359","article-title":"FcRn is a CD32a coreceptor that determines susceptibility to IgG immune complex-driven autoimmunity","volume":"217","author":"Hubbard","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2021.103016_bb0250","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/blood.V62.2.480.480","article-title":"Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic Purpura","volume":"62","author":"Bussel","year":"1983","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.103016_bb0255","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM198608073150601","article-title":"The treatment of Kawasaki syndrome with intravenous gamma globulin","volume":"315","author":"Newburger","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2021.103016_bb0260","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","article-title":"A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis","volume":"329","author":"Dalakas","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2021.103016_bb0265","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/biom6010015","article-title":"The production processes and biological effects of intravenous immunoglobulin","volume":"6","author":"Barahona Afonso","year":"2016","journal-title":"Biomolecules"},{"key":"10.1016\/j.autrev.2021.103016_bb0270","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1126\/science.291.5503.484","article-title":"Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor","volume":"291","author":"Samuelsson","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.autrev.2021.103016_bb0275","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1182\/blood-2002-05-1447","article-title":"Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin","volume":"101","author":"Bayry","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.103016_bb0280","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1172\/JCI74572","article-title":"Shifting Fc\u03b3RIIA-ITAM from activation to inhibitory configuration ameliorates arthritis","volume":"124","author":"Ben Mkaddem","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2021.103016_bb0285","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/ard.54.5.382","article-title":"Long term treatment of rheumatoid arthritis with high doses of intravenous immunoglobulins: effects on disease activity and serum cytokines","volume":"54","author":"Muscat","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.103016_bb0290","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1093\/rheumatology\/keq021","article-title":"The role of high-dose intravenous immunoglobulin in rheumatology","volume":"49","author":"Vaitla","year":"2010","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.autrev.2021.103016_bb0295","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/cei.13532","article-title":"IVIG ameliorate inflammation in collagen-induced arthritis: projection for IVIG therapy in rheumatoid arthritis","volume":"203","author":"Halpert","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0300","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.autrev.2016.03.018","article-title":"IVIG in autoimmune disease - potential next generation biologics","volume":"15","author":"Zuercher","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.103016_bb0305","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2147\/ITT.S266242","article-title":"IgA and Fc\u03b1RI: versatile players in homeostasis, infection, and autoimmunity","volume":"9","author":"van Gool","year":"2021","journal-title":"ImmunoTargets Ther"},{"key":"10.1016\/j.autrev.2021.103016_bb0310","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1042\/bj20011696","article-title":"IgA Fc receptor (FcalphaR) cross-linking recruits tyrosine kinases, phosphoinositide kinases and serine\/threonine kinases to glycolipid rafts","volume":"364","author":"Lang","year":"2002","journal-title":"Biochem J"},{"key":"10.1016\/j.autrev.2021.103016_bb0315","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.4049\/jimmunol.1502353","article-title":"IgA complexes in plasma and synovial fluid of patients with rheumatoid arthritis induce neutrophil extracellular traps via Fc\u03b1RI","volume":"197","author":"Aleyd","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0320","first-page":"303","article-title":"IgA- and secretory IgA-opsonized S. aureus induce a respiratory burst and phagocytosis by polymorphonuclear leucocytes","volume":"61","author":"Gorter","year":"1987","journal-title":"Immunology"},{"issue":"137","key":"10.1016\/j.autrev.2021.103016_bb0325","first-page":"e1","article-title":"Immunoglobulin A: Fc(alpha)RI interactions induce neutrophil migration through release of leukotriene B4","volume":"2009","author":"van der Steen","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2021.103016_bb0330","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1182\/blood.V97.1.205","article-title":"Presentation of ovalbumin internalized via the immunoglobulin-A Fc receptor is enhanced through Fc receptor gamma-chain signaling","volume":"97","author":"Shen","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.103016_bb0335","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/03009749509095183","article-title":"Raised IgA rheumatoid factor (RF) but not IgM RF or IgG RF is associated with extra-articular manifestations in rheumatoid arthritis","volume":"24","author":"J\u00f3nsson","year":"1995","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2021.103016_bb0340","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/art.21691","article-title":"Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis","volume":"55","author":"Caspi","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.103016_bb0345","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s13075-020-02363-0","article-title":"Presence of salivary IgA anti-citrullinated protein antibodies associate with higher disease activity in patients with rheumatoid arthritis","volume":"22","author":"Roos Ljungberg","year":"2020","journal-title":"Arthritis Res Ther"},{"issue":"192","key":"10.1016\/j.autrev.2021.103016_bb0350","first-page":"2374","article-title":"IgA enhances NETosis and release of neutrophil extracellular traps by polymorphonuclear cells via Fc\u03b1 receptor I","volume":"2014","author":"Aleyd","year":"1950","journal-title":"J Immunol Baltim Md"},{"key":"10.1016\/j.autrev.2021.103016_bb0355","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keab289","article-title":"Are neutrophil extracellular traps the link for the cross-talk between periodontitis and rheumatoid arthritis physiopathology?","author":"Oliveira","year":"2021","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.autrev.2021.103016_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192365","article-title":"Circulating levels of carbamylated protein and neutrophil extracellular traps are associated with periodontitis severity in patients with rheumatoid arthritis: a pilot case-control study","volume":"13","author":"Kaneko","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2021.103016_bb0365","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/art.39142","article-title":"Reversal of arthritis by human monomeric IgA through the receptor-mediated SH2 domain-containing phosphatase 1 inhibitory pathway","volume":"67","author":"Rossato","year":"2015","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.autrev.2021.103016_bb0370","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2249.2010.04210.x","article-title":"CD23\/Fc\u03b5RII: molecular multi-tasking","volume":"162","author":"Acharya","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0375","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1365-2249.2009.03980.x","article-title":"Functional and clinical consequences of Fc receptor polymorphic and copy number variants","volume":"157","author":"Bournazos","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0380","doi-asserted-by":"crossref","first-page":"24083","DOI":"10.1074\/jbc.M703195200","article-title":"Soluble CD23 monomers inhibit and oligomers stimulate IGE synthesis in human B cells","volume":"282","author":"McCloskey","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2021.103016_bb0385","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.4049\/jimmunol.1601028","article-title":"Distinct expression and function of Fc\u03b5RII in human B cells and monocytes","volume":"198","author":"Peng","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0390","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/art.1780360215","article-title":"Increased production of soluble CD23 in rheumatoid arthritis, and its regulation by interleukin-4","volume":"36","author":"Chomarat","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.103016_bb0395","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1046\/j.1365-2249.2000.01198.x","article-title":"Increased synovial fluid levels of soluble CD23 are associated with an erosive status in rheumatoid arthritis (RA)","volume":"120","author":"Ribbens","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004834","article-title":"Molecular blocking of CD23 supports its role in the pathogenesis of arthritis","volume":"4","author":"Rambert","year":"2009","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2021.103016_bb0405","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nm0895-781","article-title":"Marked amelioration of established collagen-induced arthritis by treatment with antibodies to CD23 in vivo","volume":"1","author":"Plater-Zyberk","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2021.103016_bb0410","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/eji.201546266","article-title":"Increased numbers of CD23(+) CD21(hi) Bin-like B cells in human reactive and rheumatoid arthritis lymph nodes","volume":"46","author":"Kuzin","year":"2016","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0415","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/rheumatology\/key428","article-title":"Effect of rituximab treatment on T and B cell subsets in lymph node biopsies of patients with rheumatoid arthritis","volume":"58","author":"Ramwadhdoebe","year":"2019","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.autrev.2021.103016_bb0420","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/eji.201646547","article-title":"The enigmatic function of IgD: some answers at last","volume":"48","author":"Gutzeit","year":"2018","journal-title":"Eur J Immunol"},{"issue":"145","key":"10.1016\/j.autrev.2021.103016_bb0425","first-page":"3556","article-title":"IgD-receptor-positive human T lymphocytes. I. Modulation of receptor expression by oligomeric IgD and lymphokines","volume":"1990","author":"Coico","year":"1950","journal-title":"J Immunol Baltim Md"},{"key":"10.1016\/j.autrev.2021.103016_bb0430","article-title":"The elevated secreted immunoglobulin D enhanced the activation of peripheral blood mononuclear cells in rheumatoid arthritis","volume":"11","author":"Wu","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1016\/j.autrev.2021.103016_bb0435","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3389\/fimmu.2020.00755","article-title":"Regulation of T cell activities in rheumatoid arthritis by the novel fusion protein IgD-Fc-Ig","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0440","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/aps.2017.105","article-title":"The immunoglobulin D Fc receptor expressed on fibroblast-like synoviocytes from patients with rheumatoid arthritis contributes to the cell activation","volume":"38","author":"Wu","year":"2017","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.autrev.2021.103016_bb0445","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/s41401-019-0337-2","article-title":"IgD-fc-Ig fusion protein, a new biological agent, inhibits T cell function in CIA rats by inhibiting IgD-IgDR-Lck-NF-\u03baB signaling pathways","volume":"41","author":"Han","year":"2020","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.autrev.2021.103016_bb0450","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00296-016-3495-2","article-title":"Investigation of the human FCRL1, 2, and 4 gene expressions in patients with rheumatoid arthritis","volume":"36","author":"Khanzadeh","year":"2016","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2021.103016_bb0455","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1136\/annrheumdis-2013-204116","article-title":"Expression of FcRL4 defines a pro-inflammatory, RANKL-producing B cell subset in rheumatoid arthritis","volume":"74","author":"Yeo","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.103016_bb0460","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaut.2017.03.004","article-title":"B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis","volume":"81","author":"Amara","year":"2017","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2021.103016_bb0465","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","article-title":"Epidemiology of primary Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis","volume":"74","author":"Qin","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.103016_bb0470","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMcp1702514","article-title":"Primary Sj\u00f6gren\u2019s syndrome","volume":"378","author":"Mariette","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2021.103016_bb0475","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e3821","article-title":"Primary Sjogren syndrome","volume":"344","author":"Ramos-Casals","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.autrev.2021.103016_bb0480","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/rheumatology\/ket349","article-title":"Systemic involvement in primary Sj\u00f6gren\u2019s syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS registry)","volume":"53","author":"Ramos-Casals","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2021.103016_bb0485","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaut.2013.11.001","article-title":"A comprehensive review of autoantibodies in primary Sj\u00f6gren\u2019s syndrome: clinical phenotypes and regulatory mechanisms","volume":"51","author":"Kyriakidis","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2021.103016_bb0490","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/bjh.13192","article-title":"Sj\u00f6gren syndrome-associated lymphomas: an update on pathogenesis and management","volume":"168","author":"Nocturne","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.autrev.2021.103016_bb0495","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.autrev.2015.07.002","article-title":"Anti-SSA\/SSB-negative Sj\u00f6gren\u2019s syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution","volume":"14","author":"Quartuccio","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.103016_bb0500","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1600-0714.2007.00563.x","article-title":"Fc\u03b3 receptors mediate internalization of anti-Ro and anti-La autoantibodies from Sj\u00f6gren\u2019s syndrome and apoptosis in human salivary gland cell line A-253","volume":"36","author":"Lisi","year":"2007","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.autrev.2021.103016_bb0505","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00296-008-0536-5","article-title":"Modulation of the Fcgamma receptors induced by anti-Ro and anti-La autoantibodies: observations in salivary gland cells","volume":"28","author":"Lisi","year":"2008","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2021.103016_bb0510","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1002\/art.22947","article-title":"Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism","volume":"56","author":"Reefman","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.103016_bb0515","first-page":"2413","article-title":"Impaired clearance of apoptotic cardiocytes is linked to anti-SSA\/Ro and -SSB\/La antibodies in the pathogenesis of congenital heart block","volume":"116","author":"Clancy","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2021.103016_bb0520","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/ard.2008.087874","article-title":"Increased frequency of CD16+ monocytes and the presence of activated dendritic cells in salivary glands in primary Sj\u00f6gren syndrome","volume":"68","author":"Wildenberg","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.103016_bb0525","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/rheumatology\/kes435","article-title":"IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren\u2019s syndrome and is associated with the local expansion of pro-inflammatory CD14(bright)CD16+ monocytes","volume":"52","author":"Ciccia","year":"2013","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.autrev.2021.103016_bb0530","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/jaut.1995.0019","article-title":"Anti-fc gamma receptor III autoantibody is associated with soluble receptor in rheumatoid arthritis serum and synovial fluid","volume":"8","author":"Lamour","year":"1995","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2021.103016_bb0535","first-page":"689","article-title":"Decreased Fcgamma receptor III (CD16) expression on peripheral blood mononuclear cells in patients with Sj\u00f6gren\u2019s syndrome","volume":"25","author":"Saito","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2021.103016_bb0540","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1006\/jaut.1996.0022","article-title":"Anti-fc gamma receptor autoantibodies from patients with Sj\u00f6gren\u2019s syndrome do not react with native receptor on human polymorphonuclear leukocytes","volume":"9","author":"Lamour","year":"1996","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2021.103016_bb0545","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1385\/CRIAI:18:1:11","article-title":"Fc-gamma receptor reactivity in nonorgan-specific autoimmune diseases","volume":"18","author":"Durand","year":"2000","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0550","doi-asserted-by":"crossref","first-page":"534","DOI":"10.7326\/0003-4819-91-4-534","article-title":"Sj\u00f6gren\u2019s syndrome: a defect in reticuloendothelial system fc-receptor-specific clearance","volume":"91","author":"Hamburger","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2021.103016_bb0555","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJM197903083001002","article-title":"Defective reticuloendothelial system fc-receptor function in systemic lupus erythematosus","volume":"300","author":"Frank","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2021.103016_bb0560","first-page":"550","article-title":"Reticuloendothelial system fc receptor function in rheumatoid arthritis","volume":"10","author":"Fields","year":"1983","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2021.103016_bb0565","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s10067-013-2344-x","article-title":"High-dose methylprednisolone pulse therapy upregulated Fc\u03b3RIIb expression on B cells in primary Sj\u00f6gren\u2019s syndrome patients with thrombocytopenia","volume":"32","author":"Chen","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2021.103016_bb0570","first-page":"543","article-title":"IgA in Sj\u00f6gren\u2019s syndrome","volume":"12","author":"Levy","year":"1994","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2021.103016_bb0575","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1006\/clim.2002.5228","article-title":"Role of salivary IgA in the pathogenesis of Sj\u00f6gren syndrome","volume":"104","author":"Berra","year":"2002","journal-title":"Clin Immunol Orlando Fla"},{"key":"10.1016\/j.autrev.2021.103016_bb0580","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/ard.58.10.623","article-title":"Ro\/SSA and La\/SSB specific IgA autoantibodies in serum of patients with Sj\u00f6gren\u2019s syndrome and systemic lupus erythematosus","volume":"58","author":"Pourmand","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.103016_bb0585","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0896-8411(91)90016-6","article-title":"IgA-containing immune complexes in the circulation of patients with primary Sj\u00f6gren\u2019s syndrome","volume":"4","author":"Bendaoud","year":"1991","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2021.103016_bb0590","first-page":"1205","article-title":"IgA rheumatoid factor and IgA containing immune complexes in primary Sj\u00f6gren\u2019s syndrome","volume":"16","author":"Atkinson","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2021.103016_bb0595","first-page":"247","article-title":"IgA glycosylation abnormalities in the serum of patients with primary Sj\u00f6gren\u2019s syndrome","volume":"13","author":"Dueymes","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2021.103016_bb0600","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1365-3083.2000.00685.x","article-title":"Increased N-linked glycosylation leading to oversialylation of monomeric immunoglobulin A1 from patients with Sj\u00f6gren\u2019s syndrome","volume":"51","author":"Basset","year":"2000","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0605","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1365-2249.1992.tb06979.x","article-title":"Soluble CD23 levels are elevated in the serum of patients with primary Sj\u00f6gren\u2019s syndrome and systemic lupus erythematosus","volume":"89","author":"Bansal","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0610","first-page":"711","article-title":"Increased soluble CD23 molecules in serum\/saliva and correlation with the stage of sialoectasis in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"13","author":"Takei","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2021.103016_bb0615","first-page":"14","article-title":"B cells in the pathogenesis of primary Sj\u00f6gren syndrome","author":"Nocturne","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2021.103016_bb0620","article-title":"IgE Autoantibodies Against SSA and SSB in Patients with Sj\u00f6gren's Syndrome and Healthy Controls","year":"2012","journal-title":"ACR Meet Abstr"},{"key":"10.1016\/j.autrev.2021.103016_bb0625","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1084\/jem.167.5.1560","article-title":"A 52-kD protein is a novel component of the SS-A\/Ro antigenic particle","volume":"167","author":"Ben-Chetrit","year":"1988","journal-title":"J Exp Med"},{"issue":"Suppl. 126","key":"10.1016\/j.autrev.2021.103016_bb0630","first-page":"134","article-title":"Anti-Ro52 and\/or anti-Ro60 immune reactivity: autoantibody and disease associations","volume":"38","author":"Zampeli","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2021.103016_bb0635","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02049","article-title":"TRIM21\u2014from intracellular immunity to therapy","volume":"10","author":"Foss","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0640","doi-asserted-by":"crossref","first-page":"10440","DOI":"10.1073\/pnas.1806314115","article-title":"TRIM21 mediates antibody inhibition of adenovirus-based gene delivery and vaccination","volume":"115","author":"Bottermann","year":"2018","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.autrev.2021.103016_bb0645","doi-asserted-by":"crossref","first-page":"19985","DOI":"10.1073\/pnas.1014074107","article-title":"Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)","volume":"107","author":"Mallery","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.autrev.2021.103016_bb0650","doi-asserted-by":"crossref","first-page":"13463","DOI":"10.1073\/pnas.1410980111","article-title":"Translocalized IgA mediates neutralization and stimulates innate immunity inside infected cells","volume":"111","author":"Bidgood","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2021.103016_bb0655","article-title":"Surveillance for intracellular antibody by cytosolic Fc receptor TRIM21","volume":"5","author":"McEwan","year":"2016","journal-title":"Antibodies Basel Switz"},{"key":"10.1016\/j.autrev.2021.103016_bb0660","doi-asserted-by":"crossref","first-page":"19733","DOI":"10.1073\/pnas.1210659109","article-title":"AAA ATPase p97\/VCP is essential for TRIM21-mediated virus neutralization","volume":"109","author":"Hauler","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2021.103016_bb0665","doi-asserted-by":"crossref","first-page":"10014","DOI":"10.1073\/pnas.1507534112","article-title":"Sequential ubiquitination and deubiquitination enzymes synchronize the dual sensor and effector functions of TRIM21","volume":"112","author":"Fletcher","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2021.103016_bb0670","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.molimm.2005.04.013","article-title":"Structural, functional and immunologic characterization of folded subdomains in the Ro52 protein targeted in Sj\u00f6gren\u2019s syndrome","volume":"43","author":"Ottosson","year":"2006","journal-title":"Mol Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0675","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jaut.2012.01.014","article-title":"The immunobiology of Ro52 (TRIM21) in autoimmunity: a critical review","volume":"39","author":"Oke","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2021.103016_bb0680","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/ni.2492","article-title":"The E3 ubiquitin ligase TRIM21 negatively regulates the innate immune response to intracellular double-stranded DNA","volume":"14","author":"Zhang","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0685","doi-asserted-by":"crossref","first-page":"36478","DOI":"10.1074\/jbc.M111.241786","article-title":"Anti-Ro52 autoantibodies from patients with Sj\u00f6gren\u2019s syndrome inhibit the Ro52 E3 ligase activity by blocking the E3\/E2 interface","volume":"286","author":"Espinosa","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2021.103016_bb0690","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1083\/jcb.201503023","article-title":"TRIM-mediated precision autophagy targets cytoplasmic regulators of innate immunity","volume":"210","author":"Kimura","year":"2015","journal-title":"J Cell Biol"},{"key":"10.1016\/j.autrev.2021.103016_bb0695","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/annrheumdis-2014-206297","article-title":"Interaction between innate immunity and Ro52-induced antibody causes Sj\u00f6gren\u2019s syndrome-like disorder in mice","volume":"75","author":"Szczerba","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.103016_bb0700","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1365-3083.2002.01072_79.x","article-title":"Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sj\u00f6gren\u2019s syndrome","volume":"56","author":"Ohlsson","year":"2002","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0705","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/art.21005","article-title":"Salivary gland epithelial cell exosomes: a source of autoantigenic ribonucleoproteins","volume":"52","author":"Kapsogeorgou","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.103016_bb0710","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19102935","article-title":"Immune response targeting Sj\u00f6gren\u2019s syndrome antigen Ro52 suppresses tear production in female mice","volume":"19","author":"Trzeciak","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2021.103016_bb0715","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/cei.13211","article-title":"The Sj\u00f6gren\u2019s syndrome-associated autoantigen Ro52\/TRIM21 modulates follicular B cell homeostasis and immunoglobulin production","volume":"194","author":"Brauner","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0720","article-title":"Antibodies to both Ro52 and Ro60 may identify Sj\u00f6gren\u2019s syndrome patients best suited for clinical trials of disease-modifying therapies","author":"Arma\u011fan","year":"2021","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2021.103016_bb0725","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.105895","article-title":"Anti-Ro52 antibodies are a risk factor for interstitial lung disease in primary Sj\u00f6gren syndrome","volume":"163","author":"Buvry","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.autrev.2021.103016_bb0730","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.autrev.2011.03.004","article-title":"Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentric study","volume":"10","author":"Ghillani","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.103016_bb0735","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2017.03.012","article-title":"FcRL4+ B-cells in salivary glands of primary Sj\u00f6gren\u2019s syndrome patients","volume":"81","author":"Haacke","year":"2017","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2021.103016_bb0740","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.1182\/blood-2011-05-353102","article-title":"FcRL4 acts as an adaptive to innate molecular switch dampening BCR signaling and enhancing TLR signaling","volume":"118","author":"Sohn","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.103016_bb0745","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10030532","article-title":"Making sense of intracellular nucleic acid sensing in type I interferon activation in Sj\u00f6gren\u2019s syndrome","volume":"10","author":"Huijser","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2021.103016_bb0750","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2021.103016_bb0755","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.autrev.2011.10.020","article-title":"Systemic lupus erythematosus one disease or many?","volume":"11","author":"Agmon-Levin","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.103016_bb0760","doi-asserted-by":"crossref","DOI":"10.7326\/AITC202006020","article-title":"Systemic lupus erythematosus","volume":"172","author":"Kiriakidou","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2021.103016_bb0765","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","article-title":"New insights into the immunopathogenesis of systemic lupus erythematosus","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2021.103016_bb0770","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41584-020-0480-7","article-title":"New insights into the role of antinuclear antibodies in systemic lupus erythematosus","volume":"16","author":"Pisetsky","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2021.103016_bb0775","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nri3607","article-title":"Apoptotic cell clearance: basic biology and therapeutic potential","volume":"14","author":"Poon","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0780","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H","article-title":"Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus","volume":"41","author":"Herrmann","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"137","key":"10.1016\/j.autrev.2021.103016_bb0785","first-page":"91","article-title":"Mononuclear phagocyte function in SLE. I. Bipartite fc- and complement-dependent dysfunction","volume":"1986","author":"Kimberly","year":"1950","journal-title":"J Immunol Baltim Md"},{"key":"10.1016\/j.autrev.2021.103016_bb0790","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1084\/jem.179.4.1317","article-title":"Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes","volume":"179","author":"Casciola-Rosen","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2021.103016_bb0795","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1084\/jem.181.4.1557","article-title":"Novel packages of viral and self-antigens are generated during apoptosis","volume":"181","author":"Rosen","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2021.103016_bb0800","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1073\/pnas.93.4.1624","article-title":"Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus","volume":"93","author":"Casciola-Rosen","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2021.103016_bb0805","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.4049\/jimmunol.1500418","article-title":"Apoptotic debris accumulates on hematopoietic cells and promotes disease in murine and human systemic lupus erythematosus","volume":"196","author":"Kang","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0810","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1177\/0961203315579093","article-title":"Monocyte CD64 expression as a novel biomarker for the disease activity of systemic lupus erythematosus","volume":"24","author":"Kikuchi-Taura","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2021.103016_bb0815","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.autrev.2017.11.009","article-title":"Targeting interferons and their pathways in systemic lupus erythematosus","volume":"17","author":"Chasset","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.103016_bb0820","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jphs.2018.05.012","article-title":"Lentivirus-mediated knockdown of Fc\u03b3RI (CD64) attenuated lupus nephritis via inhibition of NF-\u03baB regulating NLRP3 inflammasome activation in MRL\/lpr mice","volume":"137","author":"Zhang","year":"2018","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.autrev.2021.103016_bb0825","doi-asserted-by":"crossref","first-page":"15160","DOI":"10.1073\/pnas.2000943117","article-title":"Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis","volume":"117","author":"Jing","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2021.103016_bb0830","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s10067-018-4334-5","article-title":"Utility of neutrophil CD64 and serum TREM-1 in distinguishing bacterial infection from disease flare in SLE and ANCA-associated vasculitis","volume":"38","author":"Ajmani","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2021.103016_bb0835","doi-asserted-by":"crossref","first-page":"15208","DOI":"10.1096\/fj.202001085R","article-title":"IgG-aggregates rapidly upregulate FcgRI expression at the surface of human neutrophils in a FcgRII-dependent fashion: a crucial role for FcgRI in the generation of reactive oxygen species","volume":"34","author":"Huot","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.autrev.2021.103016_bb0840","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/BOR.0000000000000577","article-title":"Neutrophils in lupus nephritis","volume":"31","author":"Nishi","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2021.103016_bb0845","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.4049\/jimmunol.171.6.3296","article-title":"Fc\u03b3RIIa is expressed on natural IFN-\u03b1-producing cells (plasmacytoid dendritic cells) and is required for the IFN-\u03b1 production induced by apoptotic cells combined with lupus IgG","volume":"171","author":"B\u00e5ve","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0850","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1002\/art.39296","article-title":"Neutrophil extracellular trap mitochondrial DNA and its autoantibody in systemic lupus erythematosus and a proof-of-concept trial of metformin","volume":"67","author":"Wang","year":"2015","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.autrev.2021.103016_bb0855","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.autrev.2019.06.011","article-title":"An emerging role of neutrophils and NETosis in chronic inflammation and fibrosis in systemic lupus erythematosus (SLE) and ANCA-associated vasculitides (AAV): implications for the pathogenesis and treatment","volume":"18","author":"Frangou","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"178","key":"10.1016\/j.autrev.2021.103016_bb0860","first-page":"3272","article-title":"Expression profile of FcgammaRIIb on leukocytes and its dysregulation in systemic lupus erythematosus","volume":"2007","author":"Su","year":"1950","journal-title":"J Immunol Baltim Md"},{"key":"10.1016\/j.autrev.2021.103016_bb0865","doi-asserted-by":"crossref","first-page":"17342","DOI":"10.1038\/s41598-019-53963-z","article-title":"Lupus-like disease in Fc\u03b3RIIB\u2212\/\u2212 mice induces osteopenia","volume":"9","author":"Visitchanakun","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2021.103016_bb0870","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/ard.2006.068981","article-title":"Treatment of lupus-prone NZB\/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32)","volume":"67","author":"Werwitzke","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.103016_bb0875","article-title":"Inhibition of B cell activation following in vivo co-engagement of B cell antigen receptor and Fc\u03b3 receptor IIb in non-autoimmune-prone and SLE-prone mice","volume":"4","author":"Chu","year":"2021","journal-title":"J Transl Autoimmun"},{"key":"10.1016\/j.autrev.2021.103016_bb0880","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/annrheumdis-2019-eular.4234","article-title":"Fri0176 phase 2, double-blind, randomized, placebo-controlled study of a reversible B cell inhibitor, Xmab\u00ae5871, in systemic lupus erythematosus (sle)","volume":"78","author":"Merrill","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.103016_bb0885","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1177\/0961203320941106","article-title":"Syk inhibitor attenuates inflammation in lupus mice from FcgRIIb deficiency but not in pristane induction: the influence of lupus pathogenesis on the therapeutic effect","volume":"29","author":"Issara-Amphorn","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2021.103016_bb0890","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/art.39499","article-title":"Lupus nephritis IgG induction of calcium\/calmodulin-dependent protein kinase IV expression in podocytes and alteration of their function","volume":"68","author":"Ichinose","year":"2016","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.autrev.2021.103016_bb0895","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071458","article-title":"Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease","volume":"8","author":"Villalta","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.autrev.2021.103016_bb0900","doi-asserted-by":"crossref","first-page":"S283","DOI":"10.1067\/mjd.2002.109251","article-title":"Vesiculobullous systemic lupus erythematosus: a case with circulating IgG and IgA autoantibodies to type VII collagen","volume":"47","author":"Nitta","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2021.103016_bb0905","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/289316","article-title":"A study on clinical and pathologic features in lupus nephritis with mainly IgA deposits and a literature review","volume":"2013","author":"Hongyan","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0910","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2249.2011.04452.x","article-title":"Negative regulation of inflammatory responses by immunoglobulin a receptor (Fc\u03b1RI) inhibits the development of toll-like receptor-9 signalling-accelerated glomerulonephritis","volume":"166","author":"Watanabe","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0915","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/cei.12647","article-title":"Targeted IgA Fc receptor I (Fc\u03b1RI) therapy in the early intervention and treatment of pristane-induced lupus nephritis in mice","volume":"181","author":"Liu","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0920","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.autrev.2013.10.005","article-title":"IgA deficiency and autoimmunity","volume":"13","author":"Singh","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.103016_bb0925","first-page":"245","article-title":"The prevalence of IgE antinuclear antibodies in rheumatoid arthritis and systemic lupus erythematosus","volume":"86C","author":"Permin","year":"1978","journal-title":"Acta Pathol Microbiol Scand C"},{"key":"10.1016\/j.autrev.2021.103016_bb0930","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/art.1780160605","article-title":"Nucleolar antigen specific for antinucleolar antibody in the sera of patients with systemic rheumatic disease","volume":"16","author":"Miyawaki","year":"1973","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.103016_bb0935","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nm.2159","article-title":"Basophils and the T helper 2 environment can promote the development of lupus nephritis","volume":"16","author":"Charles","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2021.103016_bb0940","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1084\/jem.20140066","article-title":"Immunoglobulin E plays an immunoregulatory role in lupus","volume":"211","author":"Dema","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2021.103016_bb0945","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ni.3326","article-title":"Self-reactive IgE exacerbates interferon responses associated with autoimmunity","volume":"17","author":"Henault","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0950","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1172\/JCI200315932","article-title":"Evidence for a differential expression of the FcepsilonRIgamma chain in dendritic cells of atopic and nonatopic donors","volume":"111","author":"Novak","year":"2003","journal-title":"J Clin Invest"},{"issue":"162","key":"10.1016\/j.autrev.2021.103016_bb0955","first-page":"6893","article-title":"Intracellular expression and release of Fc epsilon RI alpha by human eosinophils","volume":"1999","author":"Seminario","year":"1950","journal-title":"J Immunol Baltim Md"},{"issue":"157","key":"10.1016\/j.autrev.2021.103016_bb0960","first-page":"607","article-title":"Peripheral blood dendritic cells express Fc epsilon RI as a complex composed of Fc epsilon RI alpha- and Fc epsilon RI gamma-chains and can use this receptor for IgE-mediated allergen presentation","volume":"1996","author":"Maurer","year":"1950","journal-title":"J Immunol Baltim Md"},{"key":"10.1016\/j.autrev.2021.103016_bb0965","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0091-6749(97)70033-2","article-title":"Expression of high-affinity IgE receptors (fc epsilon RI) on peripheral blood basophils, monocytes, and eosinophils in atopic and nonatopic subjects: relationship to total serum IgE concentrations","volume":"99","author":"Sihra","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0970","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/imr.12340","article-title":"Structure and dynamics of IgE-receptor interactions: Fc\u03b5RI and CD23\/Fc\u03b5RII","volume":"268","author":"Sutton","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2021.103016_bb0975","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1002\/art.39679","article-title":"IgE inhibits toll-like receptor 7- and toll-like receptor 9-mediated expression of interferon-\u03b1 by plasmacytoid dendritic cells in patients with systemic lupus erythematosus","volume":"68","author":"Khoryati","year":"2016","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.autrev.2021.103016_bb0980","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1172\/JCI511","article-title":"Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship","volume":"101","author":"Fiebiger","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2021.103016_bb0985","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jaci.2003.11.044","article-title":"Omalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophils","volume":"113","author":"Lin","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb0990","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/art.40828","article-title":"Safety and tolerability of omalizumab: a randomized clinical trial of humanized anti-IgE monoclonal antibody in systemic lupus erythematosus","volume":"71","author":"Hasni","year":"2019","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.autrev.2021.103016_bb0995","first-page":"348","article-title":"Possible different mechanisms of B cell activation in systemic lupus erythematosus and rheumatoid arthritis: opposite expression of low-affinity receptors for IgE (CD23) on their peripheral B cells","volume":"78","author":"Kumagai","year":"1989","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb1000","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1006\/immu.1994.1008","article-title":"Soluble Fc epsilon RII\/CD23 in patients with autoimmune diseases and Epstein-Barr virus-related disorders: analysis by ELISA for soluble Fc epsilon RII\/CD23","volume":"4","author":"Yoshikawa","year":"1994","journal-title":"ImmunoMethods"},{"key":"10.1016\/j.autrev.2021.103016_bb1005","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/BOR.0b013e3283535801","article-title":"Lupus and Epstein-Barr","volume":"24","author":"James","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2021.103016_bb1010","doi-asserted-by":"crossref","first-page":"14421","DOI":"10.1073\/pnas.1921139117","article-title":"Functional interplay of Epstein-Barr virus oncoproteins in a mouse model of B cell lymphomagenesis","volume":"117","author":"Sommermann","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2021.103016_bb1015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00444","article-title":"Diagnostic utility of separate anti-Ro60 and anti-Ro52\/TRIM21 antibody detection in autoimmune diseases","volume":"10","author":"Robbins","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb1020","article-title":"The MRL\/lpr mouse model: an important animal model for systemic Sj\u00f6gren syndrome and polyautoimmunity","author":"Killian","year":"2019","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2021.103016_bb1025","doi-asserted-by":"crossref","first-page":"E2142","DOI":"10.1073\/pnas.1513943113","article-title":"Defects in lysosomal maturation facilitate the activation of innate sensors in systemic lupus erythematosus","volume":"113","author":"Monteith","year":"2016","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.autrev.2021.103016_bb1030","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fimmu.2020.00098","article-title":"TRIM21 dysfunction enhances aberrant B-cell differentiation in autoimmune pathogenesis","volume":"11","author":"Kunishita","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb1035","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1136\/ard.2009.108043","article-title":"Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis","volume":"69","author":"Lyons","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.103016_bb1040","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/jid.2008.453","article-title":"High Ro52 expression in spontaneous and UV-induced cutaneous inflammation","volume":"129","author":"Oke","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2021.103016_bb1045","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1080\/14397595.2018.1436028","article-title":"Dysfunction of TRIM21 in interferon signature of systemic lupus erythematosus","volume":"28","author":"Kamiyama","year":"2018","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2021.103016_bb1050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI119517","article-title":"Receptor-mediated cellular entry of nuclear localizing anti-DNA antibodies via myosin 1","volume":"100","author":"Yanase","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2021.103016_bb1055","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jaut.2004.11.008","article-title":"Nuclear localizing anti-DNA antibodies enter cells via caveoli and modulate expression of caveolin and p53","volume":"24","author":"Yanase","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2021.103016_bb1060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02019","article-title":"Cytosolic internalization of anti-DNA antibodies by human monocytes induces production of pro-inflammatory cytokines independently of the tripartite motif-containing 21 (TRIM21)-mediated pathway","volume":"9","author":"Park","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb1065","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.bbrc.2011.12.010","article-title":"SS-A\/Ro52 promotes apoptosis by regulating Bcl-2 production","volume":"417","author":"Jauharoh","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"issue":"176","key":"10.1016\/j.autrev.2021.103016_bb1070","first-page":"6277","article-title":"The Sjogren\u2019s syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death","volume":"2006","author":"Espinosa","year":"1950","journal-title":"J Immunol Baltim Md"},{"key":"10.1016\/j.autrev.2021.103016_bb1075","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s40262-019-00818-5","article-title":"Exposure-response analyses of the effects of venetoclax, a selective BCL-2 inhibitor, on B-lymphocyte and Total lymphocyte counts in women with systemic lupus erythematosus","volume":"59","author":"Nader","year":"2020","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.autrev.2021.103016_bb1080","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.autrev.2021.103016_bb1085","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrrheum.2009.238","article-title":"Autoantibodies as predictive tools in systemic sclerosis","volume":"6","author":"Nihtyanova","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2021.103016_bb1090","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3899\/jrheum.130386","article-title":"Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR case-control study","volume":"41","author":"Ghr\u00e9nassia","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2021.103016_bb1095","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s10067-017-3597-6","article-title":"CD16-positive circulating monocytes and fibrotic manifestations of systemic sclerosis","volume":"36","author":"Lescoat","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2021.103016_bb1100","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11926-015-0505-4","article-title":"Functional autoantibodies in systemic sclerosis pathogenesis","volume":"17","author":"Kill","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2021.103016_bb1105","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/ard.2008.102400","article-title":"Anti-endothelial cell antibodies in systemic sclerosis","volume":"69","author":"Mihai","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.103016_bb1110","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/1529-0131(200011)43:11<2550::AID-ANR24>3.0.CO;2-H","article-title":"Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95","volume":"43","author":"Sgonc","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.103016_bb1115","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1182\/blood-2006-08-044669","article-title":"Antiendothelial cell antibodies mediate enhanced leukocyte adhesion to cytokine-activated endothelial cells through a novel mechanism requiring cooperation between Fc{gamma}RIIa and CXCR1\/2","volume":"109","author":"Florey","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.103016_bb1120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2340\/00015555762123","article-title":"Serum cytokine and anti-Fc gamma R autoantibody measurements in patients with systemic sclerosis","volume":"76","author":"Szegedi","year":"1996","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.autrev.2021.103016_bb1125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1568-9972(01)00002-7","article-title":"Pathogenic effects of anti-Fc gamma receptor IIIb (CD16) on polymorphonuclear neutrophils in non-organ-specific autoimmune diseases","volume":"1","author":"Youinou","year":"2002","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.103016_bb1130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/ard.48.3.201","article-title":"Anti-IgE autoantibodies in systemic sclerosis (scleroderma)","volume":"48","author":"Kaufman","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.103016_bb1135","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2014.13999","article-title":"Beyond allergy: the role of mast cells in fibrosis","volume":"144","author":"H\u00fcgle","year":"2014","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.autrev.2021.103016_bb1140","doi-asserted-by":"crossref","first-page":"182","DOI":"10.7326\/0003-4819-102-2-182","article-title":"Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis?","volume":"102","author":"Hawkins","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2021.103016_bb1145","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1186\/ar3763","article-title":"Clinical significance of antibodies to Ro52\/TRIM21 in systemic sclerosis","volume":"14","author":"Hudson","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2021.103016_bb1150","first-page":"S131","article-title":"Monospecific anti-Ro52\/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survival","volume":"33","author":"Wodkowski","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2021.103016_bb1155","first-page":"1","article-title":"Anti-Ro52\/TRIM21 is independently associated with pulmonary arterial hypertension and mortality in a cohort of systemic sclerosis patients","volume":"0","author":"Lee","year":"2021","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2021.103016_bb1160","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02835","article-title":"Anti-Ro60 Seropositivity determines anti-Ro52 epitope mapping in patients with systemic sclerosis","volume":"9","author":"Gkoutzourelas","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb1165","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/rheumatology\/keu289","article-title":"Incidence and prevalence of inflammatory myopathies: a systematic review","volume":"54","author":"Meyer","year":"2015","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.autrev.2021.103016_bb1170","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","article-title":"Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies","volume":"75","author":"Mariampillai","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.autrev.2021.103016_bb1175","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrrheum.2018.41","article-title":"Classification of myositis","volume":"14","author":"Lundberg","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2021.103016_bb1180","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrrheum.2018.56","article-title":"Autoantibodies in myositis","volume":"14","author":"McHugh","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2021.103016_bb1185","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.autrev.2018.10.004","article-title":"Autoantibodies in idiopathic inflammatory myopathies: clinical associations and laboratory evaluation by mono- and multispecific immunoassays","volume":"18","author":"Damoiseaux","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.103016_bb1190","doi-asserted-by":"crossref","first-page":"17958","DOI":"10.1038\/s41598-018-36395-z","article-title":"Patients with anti-Jo1 antibodies display a characteristic IgG Fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies","volume":"8","author":"Fernandes-Cerqueira","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2021.103016_bb1195","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1002\/art.27533","article-title":"Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis","volume":"62","author":"Ercan","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.103016_bb1200","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/annrheumdis-2013-203565","article-title":"Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis","volume":"74","author":"Rombouts","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.103016_bb1205","doi-asserted-by":"crossref","first-page":"12669","DOI":"10.1073\/pnas.1108455108","article-title":"Unique carbohydrate\u2013carbohydrate interactions are required for high affinity binding between Fc\u03b3RIII and antibodies lacking core fucose","volume":"108","author":"Ferrara","year":"2011","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.autrev.2021.103016_bb1210","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/annrheumdis-2018-215004","article-title":"Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis","volume":"78","author":"Sabbagh","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.103016_bb1215","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.3899\/jrheum.150844","article-title":"Rituximab in the treatment of Jo1 antibody-associated antisynthetase syndrome: anti-Ro52 positivity as a marker for severity and treatment response","volume":"43","author":"Bauhammer","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2021.103016_bb1220","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.semarthrit.2011.09.008","article-title":"Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody","volume":"41","author":"Marie","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.103016_bb1225","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00296-009-0884-9","article-title":"Characteristics of interstitial lung disease in SS-A positive\/Jo-1 positive inflammatory myopathy patients","volume":"29","author":"V\u00e1ncsa","year":"2009","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2021.103016_bb1230","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/08916930600623791","article-title":"In patients with antisynthetase syndrome the occurrence of anti-Ro\/SSA antibodies causes a more severe interstitial lung disease","volume":"39","author":"La Corte","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2021.103016_bb1235","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/rheumatology\/kex021","article-title":"A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies","volume":"56","author":"Pinal-Fernandez","year":"2017","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.autrev.2021.103016_bb1240","first-page":"1211","article-title":"High-dose intravenous immunoglobulins for the treatment of dermatological autoimmune diseases","volume":"15","author":"Hoffmann","year":"2017","journal-title":"JDDG J Dtsch Dermatol Ges"},{"key":"10.1016\/j.autrev.2021.103016_bb1245","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0002-9343(72)90064-2","article-title":"Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)","volume":"52","author":"Sharp","year":"1972","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2021.103016_bb1250","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/1529-0131(199805)41:5<768::AID-ART3>3.0.CO;2-Z","article-title":"Mixed connective tissue disease: to be or not to be?","volume":"41","author":"Smolen","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.103016_bb1255","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/ard.2010.143792","article-title":"PAHNOR1 study group. The prevalence and incidence of mixed connective tissue disease: a national multicentre survey of Norwegian patients","volume":"70","author":"Gunnarsson","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.103016_bb1260","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/271067a0","article-title":"Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors","volume":"271","author":"Alarcon-Segovia","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2021.103016_bb1265","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2249.1991.tb08128.x","article-title":"Antibody penetration of viable human cells. I. Increased penetration of human lymphocytes by anti-RNP IgG","volume":"84","author":"Ma","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb1270","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1365-2249.1993.tb08191.x","article-title":"Antibody penetration of viable human cells. II. Anti-RNP antibodies binding to RNP antigen expressed on cell surface, which may mediate the antibody internalization","volume":"93","author":"Ma","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb1275","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.jaci.2020.12.622","article-title":"Basophils and IgE contribute to mixed connective tissue disease development","volume":"147","author":"Lamri","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb1280","doi-asserted-by":"crossref","DOI":"10.5402\/2012\/415272","article-title":"Anti-ro52 antibodies and interstitial lung disease in connective tissue diseases excluding scleroderma","volume":"2012","author":"Ferreira","year":"2012","journal-title":"ISRN Rheumatol"},{"key":"10.1016\/j.autrev.2021.103016_bb1285","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/rheumatology\/kev300","article-title":"Associations between anti-Ro52 antibodies and lung fibrosis in mixed connective tissue disease","volume":"55","author":"Gunnarsson","year":"2016","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.autrev.2021.103016_bb1290","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrgastro.2013.117","article-title":"Extraintestinal manifestations and complications in IBD","volume":"10","author":"Ott","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2021.103016_bb1295","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"The Lancet"},{"key":"10.1016\/j.autrev.2021.103016_bb1300","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1056\/NEJMra2002697","article-title":"Pathophysiology of inflammatory bowel diseases","volume":"383","author":"Chang","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2021.103016_bb1305","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/eji.202048622","article-title":"Fc\u03b3RI plays a critical role in patients with ulcerative colitis relapse","volume":"51","author":"Li","year":"2021","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb1310","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.2353\/ajpath.2008.080487","article-title":"Fc gamma receptor signaling in mast cells links microbial stimulation to mucosal immune inflammation in the intestine","volume":"173","author":"Chen","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2021.103016_bb1315","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.clim.2007.07.008","article-title":"Hyperexpression of FcgammaRI and toll-like receptor 4 in the intestinal mast cells of Crohn\u2019s disease patients","volume":"125","author":"Kobayashi","year":"2007","journal-title":"Clin Immunol Orlando Fla"},{"key":"10.1016\/j.autrev.2021.103016_bb1320","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1136\/gutjnl-2012-303063","article-title":"Mucosal CXCR4+ IgG plasma cells contribute to the pathogenesis of human ulcerative colitis through Fc\u03b3R-mediated CD14 macrophage activation","volume":"62","author":"Uo","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2021.103016_bb1325","first-page":"1037","article-title":"Utility of neutrophil Fc\u03b3 receptor I (CD64) index as a biomarker for mucosal inflammation in pediatric Crohn\u2019s disease","volume":"20","author":"Minar","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2021.103016_bb1330","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/ajg.2008.6","article-title":"Expression of the high-affinity IgG receptor FcRI (CD64) in patients with inflammatory bowel disease: a new biomarker for gastroenterologic diagnostics","volume":"104","author":"Tillinger","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2021.103016_bb1335","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.immuni.2019.02.006","article-title":"Anti-commensal IgG drives intestinal inflammation and type 17 immunity in ulcerative colitis","volume":"50","author":"Castro-Dopico","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2021.103016_bb1340","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/19490976.2019.1626683","article-title":"Dynamic immunoglobulin responses to gut bacteria during inflammatory bowel disease","volume":"11","author":"Rengarajan","year":"2020","journal-title":"Gut Microbes"},{"key":"10.1016\/j.autrev.2021.103016_bb1345","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmgh.2021.03.002","article-title":"Neutrophil extracellular traps in inflammatory bowel disease: pathogenic mechanisms and clinical translation","author":"Drury","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2021.103016_bb1350","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/gut.38.4.564","article-title":"Soluble Fc gamma receptor III (CD 16) and eicosanoid concentrations in gut lavage fluid from patients with inflammatory bowel disease: reflection of mucosal inflammation","volume":"38","author":"Hommes","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2021.103016_bb1355","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/MNH.0b013e3283456731","article-title":"Pathogenesis of ANCA Vasculitis","volume":"20","author":"Jennette","year":"2011","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.autrev.2021.103016_bb1360","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/mi.2012.24","article-title":"The role of neutrophils during intestinal inflammation","volume":"5","author":"Fournier","year":"2012","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb1365","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/imm.12114","article-title":"Circulating CD4(+) and CD8(+) T cells are activated in inflammatory bowel disease and are associated with plasma markers of inflammation","volume":"140","author":"Funderburg","year":"2013","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2021.103016_bb1370","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.4049\/jimmunol.148.8.2363","article-title":"In vitro and in vivo activation of murine gamma\/delta T cells induces the expression of IgA, IgM, and IgG Fc receptors","volume":"148","author":"Sandor","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb1375","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/978-1-4684-5535-9_100","article-title":"Activated Fc alpha T cells in Crohn\u2019s disease are involved in regulation of IgA","volume":"237","author":"Raedler","year":"1988","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.autrev.2021.103016_bb1380","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-2249.1993.tb05962.x","article-title":"Increased spontaneous secretion of rheumatoid factor by intestinal lamina propria mononuclear cells from Crohn\u2019s disease but not ulcerative colitis patients","volume":"92","author":"MacDermott","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb1385","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00553","article-title":"IgA and Fc\u03b1RI: pathological roles and therapeutic opportunities","volume":"10","author":"Breedveld","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb1390","doi-asserted-by":"crossref","first-page":"ra24","DOI":"10.1126\/scisignal.2001309","article-title":"Inhibitory ITAM signaling traps activating receptors with the phosphatase SHP-1 to form polarized \u201cinhibisome\u201d clusters","volume":"4","author":"Pfirsch-Maisonnas","year":"2011","journal-title":"Sci Signal"},{"key":"10.1016\/j.autrev.2021.103016_bb1395","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10067-020-05166-5","article-title":"Multisystemic manifestations of IgA vasculitis","volume":"40","author":"Du","year":"2021","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2021.103016_bb1400","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/rheumatology\/kex158","article-title":"Incidence of IgA vasculitis in children estimated by four-source capture-recapture analysis: a population-based study","volume":"56","author":"Piram","year":"2017","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.autrev.2021.103016_bb1405","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/BOR.0b013e32835d8e2a","article-title":"Epidemiology of immunoglobulin A vasculitis (Henoch-Sch\u00f6nlein): current state of knowledge","volume":"25","author":"Piram","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2021.103016_bb1410","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.autrev.2017.10.009","article-title":"New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Sch\u00f6nlein purpura)","volume":"16","author":"Heineke","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.103016_bb1415","first-page":"1579","article-title":"Value of biomarkers for predicting immunoglobulin a vasculitis nephritis outcome in an adult prospective cohort","volume":"33","author":"Berthelot","year":"2018","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"key":"10.1016\/j.autrev.2021.103016_bb1420","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1046\/j.1365-2249.2002.01964.x","article-title":"The level of IgA antibodies to human umbilical vein endothelial cells can be enhanced by TNF-alpha treatment in children with Henoch-Sch\u00f6nlein purpura","volume":"130","author":"Yang","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb1425","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2249.2006.03076.x","article-title":"Circulating IgA from acute stage of childhood Henoch-Sch\u00f6nlein purpura can enhance endothelial interleukin (IL)-8 production through MEK\/ERK signalling pathway","volume":"144","author":"Yang","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb1430","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","article-title":"Beh\u00e7et\u2019s disease","volume":"341","author":"Sakane","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2021.103016_bb1435","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.autrev.2017.12.006","article-title":"Beh\u00e7et\u2019s disease: new insights into pathophysiology, clinical features and treatment options","volume":"17","author":"Greco","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.103016_bb1440","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01067","article-title":"Beh\u00e7et\u2019s disease: an overview of etiopathogenesis","volume":"10","author":"Leccese","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb1445","first-page":"849","article-title":"Neutrophil CD64 expression in Beh\u00e7et\u2019s disease","volume":"32","author":"Ureten","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2021.103016_bb1450","article-title":"Aberrant Fc\u03b3RIIb and Fc\u03b3RIII expression on monocytes from patients with Beh\u00e7et\u2019s disease","volume":"219","author":"Huang","year":"2020","journal-title":"Clin Immunol Orlando Fla"},{"key":"10.1016\/j.autrev.2021.103016_bb1455","doi-asserted-by":"crossref","first-page":"8162","DOI":"10.1038\/srep08162","article-title":"Annexin A2 as a target endothelial cell membrane autoantigen in Beh\u00e7et\u2019s disease","volume":"5","author":"Chen","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2021.103016_bb1460","doi-asserted-by":"crossref","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term Management of Kawasaki Disease: a scientific statement for health professionals from the American Heart Association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2021.103016_bb1465","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrrheum.2015.54","article-title":"Kawasaki disease: insights into pathogenesis and approaches to treatment","volume":"11","author":"Shulman","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2021.103016_bb1470","first-page":"1","article-title":"Kawasaki disease: pathophysiology and insights from mouse models","author":"Noval Rivas","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2021.103016_bb1475","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210446","article-title":"SARS-CoV-2-related MIS-C: a key to the viral and genetic causes of Kawasaki disease?","volume":"218","author":"Sancho-Shimizu","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2021.103016_bb1480","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102597","article-title":"Covid-19 and autoimmunity","volume":"19","author":"Ehrenfeld","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.103016_bb1485","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102695","article-title":"SARS-CoV-2, the autoimmune virus","volume":"19","author":"Halpert","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.103016_bb1490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.intimp.2017.01.022","article-title":"Expression of fc<gamma>Rs on monocytes among Kawasaki disease patients with coronary artery lesions","volume":"45","author":"Xia","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.autrev.2021.103016_bb1495","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.18632\/oncotarget.13489","article-title":"The effect of Fc\u03b3RIIA and Fc\u03b3RIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease","volume":"8","author":"Chang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.autrev.2021.103016_bb1500","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keaa089","article-title":"An update on the epidemiology of ANCA-associated vasculitis","volume":"59","author":"Mohammad","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2021.103016_bb1505","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.autrev.2008.03.009","article-title":"Natural and disease associated anti-myeloperoxidase (MPO) autoantibodies","volume":"7","author":"Guilpain","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.103016_bb1510","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/BOR.0000000000000145","article-title":"Emerging concepts in the pathogenesis of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"27","author":"Flint","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2021.103016_bb1515","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.571933","article-title":"Pathogenicity of proteinase 3-anti-neutrophil cytoplasmic antibody in granulomatosis with polyangiitis: implications as biomarker and future therapies","volume":"12","author":"Granel","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb1520","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.autrev.2008.01.003","article-title":"Membrane-bound proteinase 3 and its receptors: relevance for the pathogenesis of Wegener\u2019s Granulomatosis","volume":"8","author":"Hu","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.103016_bb1525","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1681\/ASN.2009090984","article-title":"IgG glycan hydrolysis attenuates ANCA-mediated glomerulonephritis","volume":"21","author":"van Timmeren","year":"2010","journal-title":"J Am Soc Nephrol JASN"},{"key":"10.1016\/j.autrev.2021.103016_bb1530","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213215","article-title":"Immunoglobulins G from patients with ANCA-associated vasculitis are atypically glycosylated in both the Fc and Fab regions and the relation to disease activity","volume":"14","author":"Lardinois","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.autrev.2021.103016_bb1535","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1046\/j.1365-2249.2003.02280.x","article-title":"Involvement of Fcgamma receptors and beta2 integrins in neutrophil activation by anti-proteinase-3 or anti-myeloperoxidase antibodies","volume":"134","author":"Reumaux","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb1540","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.87379","article-title":"Anti-myeloperoxidase antibodies attenuate the monocyte response to LPS and shape macrophage development","volume":"2","author":"Popat","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.autrev.2021.103016_bb1545","doi-asserted-by":"crossref","DOI":"10.1038\/srep11888","article-title":"Intermediate monocytes in ANCA vasculitis: increased surface expression of ANCA autoantigens and IL-1\u03b2 secretion in response to anti-MPO antibodies","volume":"5","author":"O\u2019Brien","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2021.103016_bb1550","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/1529-0131(200107)44:7<1698::AID-ART294>3.0.CO;2-J","article-title":"Antineutrophil cytoplasmic antibodies induce human monocytes to produce oxygen radicals in vitro","volume":"44","author":"Weidner","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.103016_bb1555","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/ki.2014.189","article-title":"Fc\u03b3RIIB regulates T-cell autoreactivity, ANCA production, and neutrophil activation to suppress anti-myeloperoxidase glomerulonephritis","volume":"86","author":"Ooi","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2021.103016_bb1560","doi-asserted-by":"crossref","first-page":"20736","DOI":"10.1073\/pnas.1109227109","article-title":"IgA and IgG antineutrophil cytoplasmic antibody engagement of Fc receptor genetic variants influences granulomatosis with polyangiitis","volume":"108","author":"Kelley","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2021.103016_bb1565","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/0140-6736(92)91640-T","article-title":"Pulmonary-renal syndrome in association with anti-GBM and IgM ANCA","volume":"339","author":"Thomas","year":"1992","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.autrev.2021.103016_bb1570","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/cei.12925","article-title":"Immunoglobulin (Ig)M antibodies to proteinase 3 in granulomatosis with polyangiitis and microscopic polyangiitis","volume":"188","author":"Clain","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb1575","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s12026-019-09091-x","article-title":"IgM ANCA in healthy individuals and in patients with ANCA-associated vasculitis","volume":"67","author":"Jeffs","year":"2019","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2021.103016_bb1580","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.molimm.2004.03.031","article-title":"An IgM class anti-neutrophil cytoplasm antibody inhibits neutrophil adhesion and apoptosis via a Syk dependent signaling cascade","volume":"41","author":"Hayes","year":"2004","journal-title":"Mol Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb1585","article-title":"Role of the IgM Fc receptor in immunity and tolerance","volume":"10","author":"Liu","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb1590","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/annrheumdis-2018-213523","article-title":"Humanised effector-null Fc\u03b3RIIA antibody inhibits immune complex-mediated proinflammatory responses","volume":"78","author":"Chen","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.103016_bb1595","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.kint.2019.12.014","article-title":"Spleen tyrosine kinase inhibition is an effective treatment for established vasculitis in a pre-clinical model","volume":"97","author":"McAdoo","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2021.103016_bb1600","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/annrheumdis-2019-216561","article-title":"The 2019 American College of Rheumatology\/European league against rheumatism classification criteria for IgG4-related disease","volume":"79","author":"Wallace","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.103016_bb1605","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","article-title":"IgG4-related disease","volume":"385","author":"Kamisawa","year":"2015","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.autrev.2021.103016_bb1610","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/MPA.0b013e3182480c99","article-title":"Nationwide epidemiological survey of autoimmune pancreatitis in Japan","volume":"41","author":"Kanno","year":"2012","journal-title":"Pancreas"},{"key":"10.1016\/j.autrev.2021.103016_bb1615","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1056\/NEJM200103083441005","article-title":"High serum IgG4 concentrations in patients with sclerosing pancreatitis","volume":"344","author":"Hamano","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2021.103016_bb1620","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10266-018-0377-y","article-title":"Pathogenesis of IgG4-related disease: a critical review","volume":"107","author":"Maehara","year":"2019","journal-title":"Odontology"},{"key":"10.1016\/j.autrev.2021.103016_bb1625","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1182\/blood-2008-09-179754","article-title":"Specificity and affinity of human Fc\u03b3 receptors and their polymorphic variants for human IgG subclasses","volume":"113","author":"Bruhns","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.103016_bb1630","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1111\/jgh.14512","article-title":"Unique patterns of glycosylation in immunoglobulin subclass G4-related disease and primary sclerosing cholangitis","volume":"34","author":"Culver","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2021.103016_bb1635","first-page":"222","article-title":"Association of a polymorphism of the Fc\u03b3-receptor 2A (FCGR2A) gene with chronic periaortitis","volume":"37","author":"Alberici","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2021.103016_bb1640","first-page":"1","article-title":"B cell targeted therapy for immunoglobulin G4-related disease","volume":"0","author":"Yamamoto","year":"2021","journal-title":"Immunol Med"},{"key":"10.1016\/j.autrev.2021.103016_bb1645","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0609.2008.01206.x","article-title":"Immune thrombocytopenic purpura: epidemiology and implications for patients","author":"Michel","year":"2009","journal-title":"Eur J Haematol Suppl"},{"key":"10.1016\/j.autrev.2021.103016_bb1650","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/MOH.0b013e32833e7561","article-title":"Novel clearance mechanisms of platelets","volume":"17","author":"Grozovsky","year":"2010","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.autrev.2021.103016_bb1655","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1182\/blood.V64.1.156.156","article-title":"Autoantibodies against platelet glycoprotein Ib in patients with chronic immune thrombocytopenic purpura","volume":"64","author":"Woods","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.103016_bb1660","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3390\/jcm10040789","article-title":"Primary immune thrombocytopenia: novel insights into pathophysiology and disease management","volume":"10","author":"Singh","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2021.103016_bb1665","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1538-7836.2008.03258.x","article-title":"Primary immune thrombocytopenia: understanding pathogenesis is the key to better treatments","volume":"7","author":"Chong","year":"2009","journal-title":"J Thromb Haemost JTH"},{"key":"10.1016\/j.autrev.2021.103016_bb1670","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12758","article-title":"Associations between FCGR polymorphisms and immune thrombocytopenia: a meta-analysis","volume":"89","author":"Li","year":"2019","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb1675","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1182\/blood-2004-03-0896","article-title":"Anti-GPVI\u2013associated ITP: an acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI\/FcR\u03b3-chain complex from the human platelet surface","volume":"104","author":"Boylan","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.103016_bb1680","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1182\/blood.V100.6.2087","article-title":"Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia","volume":"100","author":"Hansen","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.103016_bb1685","first-page":"2677","article-title":"Fc receptors in immune thrombocytopenias: a target for immunomodulation?","volume":"118","author":"Psaila","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2021.103016_bb1690","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1182\/blood-2018-11-852491","article-title":"Fostamatinib for the treatment of chronic immune thrombocytopenia","volume":"133","author":"Connell","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.103016_bb1695","doi-asserted-by":"crossref","first-page":"946","DOI":"10.3389\/fimmu.2020.00946","article-title":"The changing landscape of autoimmune hemolytic anemia","volume":"11","author":"Barcellini","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.103016_bb1700","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.100648","article-title":"Diagnosis and treatment of autoimmune hemolytic anemia in adults: recommendations from the First International Consensus Meeting","volume":"41","author":"J\u00e4ger","year":"2020","journal-title":"Blood Rev"},{"key":"10.1016\/j.autrev.2021.103016_bb1705","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1182\/blood-2014-05-576835","article-title":"Inhibition of Fc\u03b3R-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and Fc\u03b3RIIb in human macrophages","volume":"124","author":"Nagelkerke","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.103016_bb1710","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1084\/jem.171.4.1333","article-title":"Phagocytosis mediated by three distinct Fc gamma receptor classes on human leukocytes","volume":"171","author":"Anderson","year":"1990","journal-title":"J Exp Med"},{"issue":"131","key":"10.1016\/j.autrev.2021.103016_bb1715","first-page":"1240","article-title":"Monocyte receptors for the Fc portion of IgG increase in number in autoimmune hemolytic anemia and other hemolytic states and are decreased by glucocorticoid therapy","volume":"1983","author":"Fries","year":"1950","journal-title":"J Immunol Baltim Md"},{"key":"10.1016\/j.autrev.2021.103016_bb1720","first-page":"3518","article-title":"Fostamatinib, a spleen tyrosine kinase (SYK) inhibitor, for the treatment of warm antibody autoimmune hemolytic anemia (wAIHA): final results of the phase 2, multicenter","volume":"134","author":"Rogers","year":"2019","journal-title":"Open-Label Study Blood"},{"key":"10.1016\/j.autrev.2021.103016_bb1725","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1182\/blood.2019003808","article-title":"How I treat warm autoimmune hemolytic anemia","volume":"137","author":"Barcellini","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.103016_bb1730","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207218","article-title":"Venous thromboembolic events during warm autoimmune hemolytic anemia","volume":"13","author":"Audia","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2021.103016_bb1735","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1182\/blood.2019001133","article-title":"FcRn augments induction of tissue factor activity by IgG-containing immune complexes","volume":"135","author":"Cines","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.103016_bb1740","first-page":"3483","article-title":"SYNT001: a humanized IgG4 monoclonal antibody that disrupts the interaction of FcRn and IgG for the treatment of IgG-mediated autoimmune diseases","volume":"130","author":"Blumberg","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.103016_bb1745","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(10)60709-X","article-title":"Antiphospholipid syndrome","volume":"376","author":"Ruiz-Irastorza","year":"2010","journal-title":"The Lancet"},{"key":"10.1016\/j.autrev.2021.103016_bb1750","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1136\/annrheumdis-2018-eular.5676","article-title":"AB1287 A population-based study on the prevalence and incidence of vascular primary antiphospholipid syndrome: a new rare disease","volume":"77","author":"Nalli","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.103016_bb1755","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/art.40901","article-title":"The epidemiology of antiphospholipid syndrome: a population-based study","volume":"71","author":"Duarte-Garc\u00eda","year":"2019","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.autrev.2021.103016_bb1760","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1182\/blood-2012-03-378646","article-title":"The significance of autoantibodies against \u03b22-glycoprotein I","volume":"120","author":"de Groot","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.103016_bb1765","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd3876","article-title":"Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19","volume":"12","author":"Zuo","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.autrev.2021.103016_bb1770","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1182\/blood-2002-05-1310","article-title":"Thrombogenicity of \u03b22-glycoprotein I\u2013dependent antiphospholipid antibodies in a photochemically induced thrombosis model in the hamster","volume":"101","author":"Jankowski","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.103016_bb1775","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/jlb.57.3.387","article-title":"Neutrophil activation by anti-beta 2 glycoprotein I monoclonal antibodies via Fc gamma receptor II","volume":"57","author":"Arvieux","year":"1995","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2021.103016_bb1780","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1002\/art.39247","article-title":"Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome","volume":"67","author":"Yalavarthi","year":"2015","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.autrev.2021.103016_bb1785","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/art.39938","article-title":"In vivo role of neutrophil extracellular traps in antiphospholipid antibody-mediated venous thrombosis","volume":"69","author":"Meng","year":"2017","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.autrev.2021.103016_bb1790","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/1529-0131(200104)44:4<876::AID-ANR144>3.0.CO;2-2","article-title":"Identification of an Fc gamma receptor-independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype","volume":"44","author":"Pierangeli","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.103016_bb1795","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"0","author":"Scully","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2021.103016_bb1800","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1182\/blood.V98.8.2442","article-title":"Heparin-induced thrombocytopenia\/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through FcgammaRIIA","volume":"98","author":"Reilly","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.103016_bb1805","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1182\/blood-2010-03-276964","article-title":"Monocyte-bound PF4 in the pathogenesis of heparin-induced thrombocytopenia","volume":"116","author":"Rauova","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.103016_bb1810","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1182\/blood-2011-06-359430","article-title":"PF4\/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of Fc\u03b3RI","volume":"119","author":"Kasthuri","year":"2012","journal-title":"Blood"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997221002986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997221002986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:24:35Z","timestamp":1761600275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997221002986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":362,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1568997221002986"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2021.103016","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fc receptors gone wrong: A comprehensive review of their roles in autoimmune and inflammatory diseases","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2021.103016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103016"}}